KBC Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,082
| Closed | -$11K | – | 1508 |
|
|
2023
Q1 | $11K | Hold |
1,082
| – | – | ﹤0.01% | 1497 |
|
|
2022
Q4 | $37K | Hold |
1,082
| – | – | ﹤0.01% | 1451 |
|
|
2022
Q3 | $52K | Hold |
1,082
| – | – | ﹤0.01% | 1385 |
|
|
2022
Q2 | $62K | Buy |
1,082
+465
| +75% | +$26.6K | ﹤0.01% | 1380 |
|
|
2022
Q1 | $50K | Buy |
617
+46
| +8% | +$3.73K | ﹤0.01% | 1243 |
|
|
2021
Q4 | $116K | Buy |
571
+84
| +17% | +$17.1K | ﹤0.01% | 1155 |
|
|
2021
Q3 | $131K | Sell |
487
-487
| -50% | -$131K | ﹤0.01% | 1129 |
|
|
2021
Q2 | $250K | Hold |
974
| – | – | ﹤0.01% | 1145 |
|
|
2021
Q1 | $292K | Hold |
974
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q4 | $1.37M | Buy |
974
+233
| +31% | +$327K | ﹤0.01% | 1101 |
|
|
2020
Q3 | $184K | Sell |
741
-9,500
| -93% | -$2.36M | ﹤0.01% | 1128 |
|
|
2020
Q2 | $3.56M | Sell |
10,241
-13,661
| -57% | -$4.75M | 0.01% | 581 |
|
|
2020
Q1 | $6.4M | Sell |
23,902
-7,072
| -23% | -$1.89M | 0.05% | 325 |
|
|
2019
Q4 | $10M | Buy |
30,974
+28,290
| +1,054% | +$9.16M | 0.06% | 322 |
|
|
2019
Q3 | $733K | Buy |
2,684
+1,691
| +170% | +$462K | 0.01% | 977 |
|
|
2019
Q2 | $530K | Hold |
993
| – | – | ﹤0.01% | 1051 |
|
|
2019
Q1 | $500K | Buy |
993
+198
| +25% | +$99.7K | ﹤0.01% | 1082 |
|
|
2018
Q4 | $392K | Buy |
795
+19
| +2% | +$9.37K | ﹤0.01% | 981 |
|
|
2018
Q3 | $710K | Hold |
776
| – | – | 0.01% | 1019 |
|
|
2018
Q2 | $569K | Buy |
+776
| New | +$569K | ﹤0.01% | 955 |
|
|
2018
Q1 | – | Sell |
-1,648
| Closed | -$1.48M | – | 1304 |
|
|
2017
Q4 | $1.48M | Buy |
+1,648
| New | +$1.48M | 0.01% | 669 |
|
|
2016
Q4 | – | Sell |
-3,161
| Closed | -$815K | – | 1323 |
|
|
2016
Q3 | $815K | Buy |
3,161
+1,700
| +116% | +$438K | 0.01% | 831 |
|
|
2016
Q2 | $312K | Buy |
+1,461
| New | +$312K | ﹤0.01% | 985 |
|